Nonalcoholic Steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD), characterized by liver inflammation and damage due to fat accumulation. Unlike simple fatty liver, NASH can progress to serious conditions such as fibrosis, cirrhosis, and liver failure. This chronic liver disease is increasingly recognized as a global health concern, with its rising prevalence linked to the growing incidence of obesity, type 2 diabetes, and metabolic syndrome. Affecting both children and adults, NASH often remains asymptomatic until it reaches an advanced stage, highlighting the need for early diagnosis and intervention. According to DelveInsight estimat...
